Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DU26FEMMH
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,397
Award facts
- Contract value 100% obligated
- $12,396.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,396.58 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This firm fixed-price delivery order, issued on October 29, 2025, with completion by October 30, 2025, represents one of numerous pharmaceutical supply orders placed with the contractor during October 2025. DMS Pharmaceutical Group supplies a comprehensive range of pharmaceutical products including branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables to support Department of Defense healthcare operations. The award carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide recurring pharmaceutical supplies to military healthcare facilities worldwide. The company's underlying IDC, designated SPE2DR and valued at $499,999,999, was awarded in November 2025 and extends through December 31, 2036, with a 30-month base period and three 30-month option periods. As a prime vendor contractor under this program, DMS Pharmaceutical Group serves as a critical supplier enabling the Department of Defense to efficiently procure and distribute specialized pharmaceutical products across its global military medical system.
Quick answers
Who was awarded contract SPE2DU26FEMMH?
SPE2DU26FEMMH was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DU26FEMMH worth?
The government has obligated $12,397 on SPE2DU26FEMMH.
Is contract SPE2DU26FEMMH an order under another contract?
Yes. SPE2DU26FEMMH is a delivery order under SPE2DU25D9517, an indefinite delivery contract.
Was contract SPE2DU26FEMMH competed?
The extent of competition for SPE2DU26FEMMH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award